All Stories

  1. Nintedanib as the First Treatment for Group of Progressive Interstitial Lung Diseases: A Review of Patent Literature

    Article • Recent Advances in Inflammation & Allergy Drug Discovery, September 2023, Bentham Science Publishers

    Pratik Vora, Dr Gaurang Dubal